DETERMINATION OF VULVOVAGINAL CANDIDIASIS IN TERTIARY CARE HOSPITAL

Authors

  • SUSHIL KUMAR Department of Pathology, Rajkiya Medical College, Jalaun, Orai, Uttar Pradesh, India,
  • ROMA GOYAL Department of Microbiology, NCR Institute of Medical Sciences, Meerut, Uttar Pradesh, India. https://orcid.org/0000-0003-0872-7274
  • ANIL KUMAR Department of Microbiology, NCR Institute of Medical Sciences, Meerut, Uttar Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i8.44302

Keywords:

Non albicans Candida Specie (NAC), Sabouraud dextrose agar (SDA),, Voriconazole(VRC),, vulvovaginal candidiasis (VCC).

Abstract

Objectives: Infections of vulva and vagina are commonly encountered in gynecology practice. These infections are predominant in the women of reproductive age group so, this study was done to determine the prevalence of vaginal candidiasis and identify, differentiate Candida species isolated from the patients. Three high vaginal swabs per patients were collected using sterile cotton-tipped swabs from Gynecology Department and processed in Department of Microbiology, MLBMC, India. Candida was identified using standard guidelines. The study was done on 350 women in reproductive age group (18–49 years), 63.4% were non-pregnant and 36.5% pregnant. One hundred and sixteen/350 (33.1%) samples showed pure growth of Candida species. Candida positivity among pregnant women (42.9%) was higher than in non-pregnant women (27.1%). Isolation of non-albican Candida was higher (26.7%) than Candida albicans, this difference was statistically significant (p<0.05) The most common isolated species by conventional methods was C. albicans (36.3%) followed by Candida glabrata (24.1%), Candida tropicalis (22.5%), Candida krusei (10.3), and Candida parapsilosis (7.7%). In case of C. albicans, Fluconazole and Amphotericin B were found to be most sensitive drugs followed by Nystatin, voriconazole and ketoconazole and among non-albicans candida, Nystatin was the highly sensitive drug. Vulvovaginal candidiasis (VCC) is the most common infection in the women reproductive age group. Several predisposing factors such as HIV, diabetes mellitus, oral contraceptive, IUCD usage, antibiotics, and immunosuppressive drug increase the VCC, C. albicans was the most prevalent species followed by C. glabrata and C. tropicalis.

Downloads

Download data is not yet available.

References

Jeanmonod R, Jeanmonod D. Vaginal Candidiasis (Vulvovaginal Candidiasis). Treasure Island, (FL): Stat Pearls Publishing; 2020.

Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal candidiasis: Epidemiological, diagnostic and therapeutic considerations. Am J Obstet Gynecol 1998;178:203-11. doi: 10.1016/ s0002-9378(98)80001-x, PMID 9500475

Nyirjesy P. Vulvovaginal candidiasis and bacterial vaginosis. Infect Dis Clin North Am 2008;22:637-52. doi: 10.1016/j.idc.2008.05.002, PMID 18954756

Kumari V, Banerjee T, Kumar P, Pandey S, Tilak R. Emergence of non- albicans Candida among candidal vulvovaginitis cases and study of their potential virulence factors from a tertiary care center, North India. Indian J Pathol Microbiol 2013;56:144-7. doi: 10.4103/0377- 4929.118703, PMID 24056652

Kalia N, Singh J, Sharma S, Kamboj SS, Arora H, Kaur M. Prevalence of vulvovaginal infections and species-specific distribution of vulvovaginal candidiasis in married women of north India. Int J Curr Microbiol Appl Sci 2015;4:253-66.

Mirza NB, Nsanze H, D’Costa LJ, Piot P. Microbiology of vaginal discharge in Nairobi, Kenya. Br J Vener Dis 1983;59:186-8. doi: 10.1136/sti.59.3.186, PMID 6405973

Otero L, Palacio V, Carreño F, Méndez FJ, Vázquez F. Vulvovaginal candidiasis in female sex workers. Int J STD AIDS 1998;9:526-30. doi: 10.1258/0956462981922764, PMID 9764936

Ugwa EA. Vulvovaginal candidiasis in Aminu Kano Teaching Hospital, North-West, Nigeria: hospital-based epidemiological study. Ann Med Health Sci Res 2015;5:274-8. doi: 10.4103/2141-9248.160185

Zarei-Mahmoudabadi M, Ghanatir ZF, Vazirianzadeh B. Candiduria in hospitalized patients in teaching hospitals of Ahvaz. Iran J Microbiol 2012;4:198-203.

Chakrabarti A, Ghosh R, Batra AK, Roy P, Singh H. Antifungal susceptibility pattern of non-albicans Candida species and distribution of species isolated from candidaemia cases over a 5 year period. Indian J Microbiol Res 1996;104:171-6.

El-sayed H, Hamouda A. Candida albicans causing vulvovaginitis and their clinical response to antifungal therapy. Egypt J Med Microbiol 2007;16:53-62.

Kotigadde BD, Rao Sunil P, Rao TV. Clinico-mycological profile of vaginal candidiasis in a tertiary care hospital in Kerala. ??? ???;???:???.

Kikani B, Kikani K, Pathak S. Effects of chemically synthesized azole compounds on clinical isolates of vaginal candidiasis, in comparison with commercially available drugs. Internet J Microbiol 2008;4:2.

Kalia N, Singh J, Sharma S, Kamboj SS. Prevalence of vulvovaginal infections and species specific distribution of vulvovaginal candidiasis in married women of North India. Int J Curr Microbiol Appl Sci 2015;4:253-66.

Muni S, Menon S, Chande C, Gohil A, Chowdhary A, Joshi A. Candida biofilm. Bombay Hosp J 2012;54:19-23.

Nayman Alpat S, Özguneş I, Ertem OT, Erben N, Doyuk Kartal E, Tözun M, et al. Evaluation of risk factors in patients with candiduria. Mikrobiyol Bul 2011;45:318-24. [View in PubMed]. PMID 21644075

Jain N, Kohli R, Cook E, Gialanella P, Chang T, Fries BC. Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl Environ Microbiol 2007;73:1697-703. doi: 10.1128/ AEM.02439-06, PMID 17261524

Lee SC, Fung CP, Lee N, See LC, Huang JS, Tsai CJ, et al. Fluconazole disk diffusion test with methylene blue- and glucose- enriched Muller- to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol 2005;43:5848-59.

Kustimur S, Kalkanci A, Mansuroglu H, Senel K. Evaluation of the disc diffusion method with a comparison study for fluconazole susceptibility of Candida strains. Chin Med J (Engl) 2003;116:633-6. PMID 12875738

Jayalakshmi L, Ratnakumari G, Samson SH. Isolation, speciation and antifungal susceptibility testing of Candida from clinical specimens at a tertiary care hospital. Sch J Appl Med Sci 2014;2:3193-8.

Doddaiah V, Dhanalakshmi T, Kulkami S. Changing trends of ulvovaginal candidiasis. J Lab Phys 2014;6:2830.

Deorukhkar SC, Saini S, Mathew S. Virulence factors contributing to pathogenicity of Candida tropicalis and its antifungal susceptibility profile. Int J Microbiol ID 2

Published

07-08-2022

How to Cite

KUMAR, S., R. GOYAL, and A. KUMAR. “DETERMINATION OF VULVOVAGINAL CANDIDIASIS IN TERTIARY CARE HOSPITAL”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 8, Aug. 2022, pp. 201-4, doi:10.22159/ajpcr.2022.v15i8.44302.

Issue

Section

Original Article(s)